Male Urinary Incontinence Market Size & Growth Forecast 2026–2035, By Segments (End-use, Incontinence Type, Usage, Distribution Channel, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Male Urinary Incontinence Market size was worth USD 7.45 Billion in 2025 and is expected to grow at a 6% CAGR between 2026 and 2035, exceeding USD 13.34 Billion by 2035. The industry revenue for 2026 is assessed at USD 7.84 billion.

• Base Year Value (2025): USD 7.45 Billion
• CAGR (2026-2035): 6%
• Forecast Year Value (2035): USD 13.34 Billion
• Historical Data Period: 2022-2025
• Largest Region: Europe
• Forecast Period: 2026-2035

Male Urinary Incontinence Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Europe accounted for 51.81% of the market in 2025, supported by mature reimbursement systems, established urology care pathways, specialized providers, and consistent long-term treatment adoption.
  • North America is expected to grow at a 6.78% CAGR, driven by greater treatment seeking, earlier diagnosis, wider specialist access, and stronger adoption of advanced continence devices and surgical solutions.

• Segment Momentum:

  • Hospitals and clinics accounted for 68.34% of the market in 2025, supported by their central role in diagnosis, specialist evaluation, treatment selection, and procedural care.
  • Mixed urinary incontinence is the fastest-growing segment as more patients present overlapping symptoms, increasing demand for tailored management approaches across care settings.

• Market Expansion Drivers:

  • Rising prostate cancer treatments increasing post-surgical urinary incontinence prevalence globally.
  • Advancements in minimally invasive continence devices improving patient adoption rates.
  • Expanding geriatric population increasing long-term demand for incontinence management solutions.

• Leading Market Participants:

  Key companies in the male urinary incontinence market include Coloplast A/S (Denmark), Boston Scientific Corporation (United States), Essity AB (Sweden), Kimberly-Clark Corporation (United States), Hollister Incorporated (United States), Cardinal Health, Inc. (United States), Becton, Dickinson and Company (United States), Teleflex Incorporated (United States), PAUL HARTMANN AG (Germany), ABENA A/S (Denmark).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 7.45 Billion
  • Projected Market Size: USD 13.34 Billion by 2035
  • Growth Forecasts: 6% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: Europe
  • High-Growth Regional Hub: North America
  • Core Revenue Segment: Hospitals & Clinics (End-use) | Urge Urinary Incontinence (Incontinence Type) | Disposable (Usage) | Offline Stores (Distribution Channel) | Absorbents (Product)
  • Emerging Opportunity Segment: Homecare (End-use) | Mixed Urinary Incontinence (Incontinence Type) | Reusable (Usage) | Online Channels (Distribution Channel) | Non-Absorbents (Product)

Market Growth Drivers and Industry Trends

Rising prostate cancer treatments increasing post-surgical urinary incontinence prevalence globally

Higher volumes of prostate cancer treatment, particularly prostatectomy and related interventions that can impair sphincter control, are creating a larger pool of men requiring ongoing continence care and corrective therapies. This directly influences the male urinary incontinence market by shifting demand beyond disposable containment products toward clinical evaluation, pelvic floor rehabilitation, slings, artificial urinary sphincters, and follow-up management pathways. As survivorship improves, providers and patients are more likely to address quality-of-life complications that may previously have gone undertreated, reinforcing market demand through longer care journeys and greater willingness to pursue targeted treatment rather than absorb symptoms as an unavoidable post-surgical outcome.

Advancements in minimally invasive continence devices improving patient adoption rates

Device innovation that reduces surgical complexity, recovery time, and procedure-related discomfort is influencing market adoption by lowering the threshold for intervention among men who might otherwise delay treatment. In the male urinary incontinence market, minimally invasive continence devices make specialist recommendation easier and improve patient acceptance because they better align with outpatient care models, faster return to daily activity, and a more manageable risk-benefit profile. That practical shift expands the treatable population, especially among patients with moderate symptoms who are dissatisfied with conservative management but hesitant to undergo more invasive surgery.

Expanding geriatric population increasing long-term demand for incontinence management solutions

A growing older male population is strengthening market development because age-related declines in bladder function, pelvic floor strength, neurological control, and comorbidity burden increase both the incidence and persistence of urinary incontinence. In the male urinary incontinence market, this translates into sustained demand for long-duration management rather than episodic treatment, with recurring need for absorbent products, catheter-based solutions, monitoring, and stepped clinical care as symptoms progress. The aging patient base also increases healthcare engagement through urology visits, chronic disease management, and post-hospital follow-up, creating more points at which incontinence is identified and treated rather than left unaddressed.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prostate cancer treatments increasing post-surgical urinary incontinence prevalence globally	2.20%	High	North America, Europe	High	Near Term
Advancements in minimally invasive continence devices improving patient adoption rates	1.90%	High	Europe, Asia Pacific	High	Near Term
Expanding geriatric population increasing long-term demand for incontinence management solutions	1.50%	Moderate	North America, Asia Pacific	High	Mid Term

Regional Demand Dynamics

Europe (Largest Region) vs North America (Fastest-Growing Region)

Europe held the leading position in 2025, accounting for a 51.81% share of the male urinary incontinence market. This leadership is supported by established urology care pathways, broad availability of continence products and treatment options, and a healthcare environment where diagnosis and long-term management are more routinely integrated into clinical practice. The region’s mature reimbursement structures and strong presence of specialized providers help sustain consistent treatment uptake, while an aging male population keeps demand anchored across both conservative management and procedural interventions.

North America is projected to expand at a 6.78% CAGR over the forecast period, with the male urinary incontinence market gaining momentum through greater treatment seeking, wider awareness of post-prostate procedure complications, and ongoing use of advanced therapeutic options. Growth is being fueled by active clinical management, higher patient access to specialist care, and stronger adoption of premium continence devices and surgical solutions in routine practice. The region’s market progression is also tied to earlier diagnosis and a care model that moves patients more quickly from symptom recognition to intervention.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Medium	High	Medium	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Moderate	Moderate	Moderate	Weak	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Low	Low
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Stable	Strong	Weak	Weak

Key Country Insights

United States

Advanced Treatment Adoption

The U.S. male urinary incontinence market is expanding through greater awareness, improved diagnosis, and broader access to treatment options. Healthcare providers increasingly incorporate advanced medical devices, rehabilitation approaches, and patient-focused care pathways into routine management.

Japan

Aging Population Care

Japan prioritizes male urinary incontinence management with products and therapies designed to address age-related healthcare needs. The country continues improving patient support through discreet treatment options and broader integration of long-term care services.

South Korea

Minimally Invasive Solutions

South Korea is encouraging adoption of advanced therapies within the male urinary incontinence market by expanding access to minimally invasive treatment approaches. Healthcare providers continue emphasizing early intervention and improved patient quality of life.

Germany

Integrated Clinical Management

Germany supports the male urinary incontinence market through coordinated clinical care and adoption of advanced treatment solutions. Healthcare providers emphasize individualized treatment plans supported by high-quality medical technologies and specialized patient services.

France

Patient-Centered Management

France continues advancing the male urinary incontinence market through greater focus on patient education, specialized clinical care, and treatment accessibility. Healthcare professionals are adopting comprehensive management strategies that improve long-term patient outcomes.

Italy

Rehabilitation-Based Care

Italy strengthens the male urinary incontinence market by integrating rehabilitation programs with medical treatment and supportive care services. Providers are expanding access to practical therapeutic solutions that improve patient confidence and daily functioning.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Homecare (Fastest-Growing Segment)

Hospitals & Clinics held the leading position in the male urinary incontinence market in 2025, accounting for a 68.34% share. This dominance is supported by the central role these settings play in diagnosis, clinical evaluation, and treatment selection for male urinary incontinence, particularly where patients require specialist assessment and structured care pathways. Hospitals and clinics also remain the primary point of access for procedural interventions and prescription-based management, which helps sustain their strong share across the care continuum.

Homecare is emerging as the fastest-growing end-use segment in the male urinary incontinence market as management increasingly extends beyond institutional settings into routine daily care. Its momentum reflects practical demand for long-term, convenient, and discreet management options that fit ongoing patient needs outside hospitals and clinics. Compared with facility-based care, homecare is experiencing stronger uptake because it better aligns with continued symptom management and regular product use in a more comfortable and accessible environment.

Incontinence Type Segment Analysis: Urge Urinary Incontinence (Largest Segment) vs Mixed Urinary Incontinence (Fastest-Growing Segment)

Within the male urinary incontinence market, Urge Urinary Incontinence represented the largest incontinence type segment in 2025, with a 59.65% share. Its leadership is maintained through the clear clinical recognition of urgency-related symptoms and the established treatment pathways associated with this condition. Because urge-related episodes often prompt patients to seek medical attention due to their disruptive nature, this segment maintains a strong share in the overall market.

Mixed Urinary Incontinence is the fastest-growing incontinence type in the male urinary incontinence market, encouraged by increasing recognition of patients presenting with overlapping symptoms rather than a single isolated condition. Growth in this segment is supported by the need for more tailored management approaches as symptom patterns become more clearly identified in clinical practice. Relative to more narrowly defined types, Mixed Urinary Incontinence is gaining momentum because it reflects a broader and more complex treatment reality that is being addressed more actively across care settings.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals & Clinics, Homecare, Others	Hospitals & Clinics	Homecare
Incontinence Type	Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Incontinence, Functional Urinary Incontinence, Mixed Urinary Incontinence	Urge Urinary Incontinence	Mixed Urinary Incontinence
Usage	Reusable, Disposable	Disposable	Reusable
Distribution Channel	Offline Stores, Online Channels	Offline Stores	Online Channels
Product	Non-Absorbents, Absorbents	Absorbents	Non-Absorbents

Competitive Landscape and Market Positioning

Key companies in the male urinary incontinence market:

1. Coloplast A/S (Denmark)

2. Boston Scientific Corporation (United States)

3. Essity AB (Sweden)

4. Kimberly-Clark Corporation (United States)

5. Hollister Incorporated (United States)

6. Cardinal Health Inc. (United States)

7. Becton Dickinson and Company (United States)

8. Teleflex Incorporated (United States)

9. PAUL HARTMANN AG (Germany)

10. ABENA A/S (Denmark)

The male urinary incontinence market is witnessing advancements in absorbent technologies, ergonomic product designs, and discreet wearable solutions aimed at improving patient convenience and confidence. Industry participants are focusing on innovative materials and enhanced comfort features to address changing consumer expectations. Integration of healthcare monitoring technologies and personalized care products is further contributing to competitive differentiation within the male urinary incontinence market.

Competitive Dynamics and Strategic Insights
Assessment Parameter	Assigned Scale	Scale Justification
Market Concentration	Medium	Mix of large players (e.g., Essity, Medline) and niche firms focusing on male-specific products.
M&A Activity / Consolidation Trend	Active	Partnerships like Medline’s QiVi MEC deal in 2024 expand male-focused solutions.
Degree of Product Differentiation	High	Male-specific devices (e.g., external catheters, QiVi MEC) offer tailored solutions.
Competitive Advantage Sustainability	Eroding	Price competition and rapid tech advancements challenge sustained advantages.
Innovation Intensity	High	Innovations like UroShield and CAUTI-prevention devices drive market growth.
Customer Loyalty / Stickiness	Moderate	Brand loyalty exists, but price sensitivity and new entrants drive switching.
Vertical Integration Level	Medium	Manufacturers produce devices but rely on external raw material suppliers.

Industry Development/News

Company Name	Date	Key Development
Coloplast	Jan-26	Coloplast signed a definitive merger agreement to acquire U.S.-based medical technology firm Uromedica. The transaction integrates Uromedica’s ProACT adjustable continence balloons into Coloplast’s global urology portfolio, expanding its treatment offerings and competitive market presence in the male surgical incontinence segment.
UroMems	Jul-25	UroMems received Investigational Device Exemption (IDE) approval from the U.S. FDA and regulatory clearance from the French ANSM. This regulatory milestone allows the company to initiate a first-of-its-kind pivotal clinical trial for its UroActive smart automated artificial urinary sphincter implant to treat male stress urinary incontinence.
Medline	Apr-24	Medline expanded its clinical urology portfolio by signing an exclusive distribution agreement for Consure Medical's QiVi MEC male external urine management device. Under the terms, Medline will distribute the non-invasive incontinence management system across acute care settings throughout North America to assist in preventing healthcare-associated infections.